2045 related articles for article (PubMed ID: 25600295)
1. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
2. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression.
Varghese E; Liskova A; Kubatka P; Mathews Samuel S; Büsselberg D
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32012744
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic and anti-tumor properties of proteasome inhibitors.
Daniel KG; Kuhn DJ; Kazi A; Dou QP
Curr Cancer Drug Targets; 2005 Nov; 5(7):529-41. PubMed ID: 16305349
[TBL] [Abstract][Full Text] [Related]
4. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
[TBL] [Abstract][Full Text] [Related]
6. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and cancer prevention: a vision.
Noonan DM; Benelli R; Albini A
Recent Results Cancer Res; 2007; 174():219-24. PubMed ID: 17302199
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
10. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products.
Wahl O; Oswald M; Tretzel L; Herres E; Arend J; Efferth T
Curr Med Chem; 2011; 18(21):3136-55. PubMed ID: 21671856
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Ramjiawan RR; Griffioen AW; Duda DG
Angiogenesis; 2017 May; 20(2):185-204. PubMed ID: 28361267
[TBL] [Abstract][Full Text] [Related]
13. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunotherapy of targeting angiogenesis.
Hou J; Tian L; Wei Y
Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
[TBL] [Abstract][Full Text] [Related]
15. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
Osada H; Kakeya H
Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
[TBL] [Abstract][Full Text] [Related]
16. A critical review on anti-angiogenic property of phytochemicals.
Rajasekar J; Perumal MK; Vallikannan B
J Nutr Biochem; 2019 Sep; 71():1-15. PubMed ID: 31174052
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
Parmar D; Apte M
Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and its regulation of tumor-induced angiogenesis.
Gupta MK; Qin RY
World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B; Kastelein AW; Klaassen I; Jansen CHJR; Latul YP; Vittori M; Biri A; Kahraman K; Griffioen AW; Amant F; Lok CAR; Schlingemann RO; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188446. PubMed ID: 33058997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
